Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart

Abstract:  To understand the mechanism of cardiovascular dysfunction in the hyperthyroid condition, the role of oxidative stress was examined in rats treated with 3,5,3′‐triiodo‐l‐thyronine (T3). Treatment of rats daily with T3 (8 μg/100 g BW) for 15 days resulted in an increase in heart weight to body weight ratio, which was ameliorated by antioxidants, melatonin (2 mg/100 g BW) or vitamin E (4 mg/100 g BW). Both melatonin and vitamin E also inhibited rises of lipid peroxidation and hydroxyl radical generation and prevented the inhibition of Cu,Zn‐superoxide dismutase in the hypertrophic heart. The expression of the glucose transporter, GLUT4, was reduced in response to T3, which was completely restored by melatonin and partially by vitamin E. However, neither antioxidant prevented down regulation of peroxisome proliferator‐activated receptor‐α in the hyperthyroid heart. Furthermore, the reduced level of myocyte enhancer factor‐2, a regulator of GLUT4 transcription was restored completely by melatonin and partially by vitamin E treatment. Glucose uptake in hypertrophic left ventricular cells was also restored by these antioxidants. The expression of B‐type natriuretic peptide, a marker of heart failure, was significantly increased by T3 and ameliorated by melatonin or vitamin E treatments. In general, the beneficial effects of melatonin given as a co‐treatment with T3 were better than those induced by vitamin E. These data show that melatonin ameliorates hypertrophic growth of the myocardium induced by hyperthyroidism and provide an insight into the mechanism of reactive oxygen species‐mediated down regulation of metabolically important genes such as GLUT4 in the heart.

[1]  R. Hardeland,et al.  Reactions of the melatonin metabolite AMK (N1‐acetyl‐5‐methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3‐acetamidomethyl‐6‐methoxycinnolinone and 3‐nitro‐AMK , 2005, Journal of pineal research.

[2]  A. Coto-Montes,et al.  A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes , 2005, Journal of pineal research.

[3]  R. Reiter,et al.  Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell‐free systems by melatonin , 2005, Journal of pineal research.

[4]  M. Medeiros,et al.  Inhibition of 5‐aminolevulinic acid‐induced DNA damage by melatonin, N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine, quercetin or resveratrol , 2005, Journal of pineal research.

[5]  R. Reiter,et al.  Melatonin mitigates mitochondrial malfunction , 2005, Journal of pineal research.

[6]  D. Bandyopadhyay,et al.  Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. , 2004, The Journal of endocrinology.

[7]  Debashis Bandyopadhyay,et al.  Melatonin protects against piroxicam‐induced gastric ulceration , 2004, Journal of pineal research.

[8]  L. Becker New concepts in reactive oxygen species and cardiovascular reperfusion physiology. , 2004, Cardiovascular research.

[9]  R. Shohet,et al.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Vanesa Martín,et al.  Regulation of antioxidant enzymes: a significant role for melatonin , 2004, Journal of pineal research.

[11]  A. Domenighetti,et al.  Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. , 2003, Journal of molecular endocrinology.

[12]  J. B. Knight,et al.  Regulation of the human GLUT4 gene promoter: Interaction between a transcriptional activator and myocyte enhancer factor 2A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Zabel,et al.  Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication , 2003, Journal of pineal research.

[14]  R. De Rosa,et al.  Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues. , 2003, Free radical biology & medicine.

[15]  C. Gentile,et al.  The chemistry of melatonin's interaction with reactive species , 2003, Journal of pineal research.

[16]  A. Shah,et al.  Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure , 2002, Hypertension.

[17]  Josep M. Guerrero,et al.  Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C , 2002, Journal of neuroscience research.

[18]  P. K. Das,et al.  Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage , 2002, Journal of pineal research.

[19]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[20]  H. Canatan,et al.  Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin‐induced diabetes mellitus , 2002, Journal of pineal research.

[21]  C. Long,et al.  Expression of TR isoforms in failing human heart. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  D. Bandyopadhyay,et al.  Gastric toxicity and mucosal ulceration induced by oxygen-derived reactive species: protection by melatonin. , 2001, Current molecular medicine.

[23]  D. Severson,et al.  Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter. , 2001, American journal of physiology. Endocrinology and metabolism.

[24]  D. H. Kim,et al.  Calcineurin regulates ryanodine receptor/Ca(2+)-release channels in rat heart. , 2000, The Biochemical journal.

[25]  M. Palacín,et al.  Role of plasma membrane transporters in muscle metabolism. , 2000, The Biochemical journal.

[26]  R. Reiter,et al.  Pharmacology and Physiology of Melatonin in the Reduction of Oxidative Stress in vivo , 2000, Neurosignals.

[27]  A. Takeshita,et al.  Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. , 2000, Circulation research.

[28]  S. Colan,et al.  Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. , 1999, Circulation.

[29]  B. Halliwell Antioxidant defence mechanisms: from the beginning to the end (of the beginning). , 1999, Free radical research.

[30]  D. Sawyer,et al.  Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. , 1999, Circulation research.

[31]  D. Kelly,et al.  Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. , 1999, The American journal of the medical sciences.

[32]  L. Videla,et al.  Protein oxidation in thyroid hormone-induced liver oxidative stress: relation to lipid peroxidation. , 1999, Toxicology letters.

[33]  M. Holness,et al.  Hyperthyroidism Facilitates Cardiac Fatty Acid Oxidation Through Altered Regulation of Cardiac Carnitine Palmitoyltransferase: Studies in Vivo and with Cardiac Myocytes , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[34]  S. Guruswamy,et al.  Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. , 1998, The Journal of biological chemistry.

[35]  I. Klein,et al.  Thyrotoxicosis and the heart. , 1998, Endocrinology and metabolism clinics of North America.

[36]  P. Venditti,et al.  Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues. , 1997, The Journal of endocrinology.

[37]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[38]  G. Shulman,et al.  Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. , 1997, Circulation.

[39]  J. Cohn Slowing the progression of heart failure. , 1996, European heart journal.

[40]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  A. Stenbit,et al.  Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 , 1995, Nature.

[42]  J. Pessin,et al.  Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. , 1994, The Journal of biological chemistry.

[43]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[44]  M. Schwaiger,et al.  Ischemia Induces Translocation of the Insulin‐Responsive Glucose Transporter GLUT4 to the Plasma Membrane of Cardiac Myocytes , 1994, Circulation.

[45]  B. Lorell,et al.  Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. , 1993, Circulation research.

[46]  G. Radda,et al.  Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 31P-NMR study. , 1990, Biochimica et biophysica acta.

[47]  W. Dillmann Biochemical basis of thyroid hormone action in the heart. , 1990, The American journal of medicine.

[48]  K. Asayama,et al.  Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. , 1987, Endocrinology.

[49]  N. Wong,et al.  Advances in our understanding of thyroid hormone action at the cellular level. , 1987, Endocrine reviews.

[50]  D. James,et al.  Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. , 1985, The American journal of physiology.

[51]  S. Marklund Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. , 1984, The Biochemical journal.

[52]  P. Spieckermann,et al.  Culturing of calcium stable adult cardiac myocytes. , 1982, Journal of molecular and cellular cardiology.

[53]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[54]  M. Lindhout,et al.  Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. , 2003, American journal of physiology. Heart and circulatory physiology.

[55]  C. Leeuwenburgh,et al.  Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. , 1997, The American journal of physiology.

[56]  K. Chien,et al.  Transcriptional regulation during cardiac growth and development. , 1993, Annual review of physiology.

[57]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[58]  R. Evans The economics of heart transplantation. , 1987, Circulation.

[59]  P. Buttrick,et al.  The cardiac hypertrophic responses to pathologic and physiologic loads. , 1987, Circulation.

[60]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[61]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[62]  J. Wiswell Hyperthyroid heart disease. , 1968, Maryland state medical journal.

[63]  Archie L. Smith [13] Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small-scale , 1967 .